Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: sore throat, body ache, low grade fever, and cough/contracted COVID after 3 Moderna doses; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (sore throat, body ache, low grade fever, and cough/contracted COVID after 3 Moderna doses) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011F21A, 038A21A and 001A21A) for COVID-19 vaccination.     Concurrent medical conditions included Hashimoto's disease (diagnosed 8 years ago but due to normal thyroid function, did not take any medications for this condition.), Hypertension, Blood cholesterol abnormal, Migraine and Osteoporosis. Concomitant products included PRAVASTATIN for Blood cholesterol abnormal, AMLODIPINE BESILATE, OLMESARTAN MEDOXOMIL (AZOR [AMLODIPINE BESILATE;OLMESARTAN MEDOXOMIL]) and METOPROLOL SUCCINATE for Hypertension, FROVATRIPTAN SUCCINATE MONOHYDRATE (FROVA) for Migraine, DENOSUMAB (PROLIA) for Osteoporosis.   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 27-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 02-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 milliliter. On 04-Jul-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced COVID-19 (sore throat, body ache, low grade fever, and cough/contracted COVID after 3 Moderna doses). The patient was treated with VITAMIN C [ASCORBIC ACID] for COVID-19, at an unspecified dose and frequency; ELDERBERRY [SAMBUCUS NIGRA] for COVID-19, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for COVID-19, at an unspecified dose and frequency. At the time of the report, COVID-19 (sore throat, body ache, low grade fever, and cough/contracted COVID after 3 Moderna doses) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 04-Jul-2022, SARS-CoV-2 test: (Positive) Positive.         It was unknown if other vaccines given within 1 month prior to Moderna COVID-19 vaccine. It was unknow if the patient had Allergies related to medications, food and other products.  The patient had received 3 doses of the Moderna COVID-19 vaccine so far, including 2 doses in the primary series and a 1st booster dose. She was scheduled for her 2nd booster dose on 09-Jul-2022 but ended up contracting COVID-19. She tested herself on 04-Jul-2022 and she was positive for COVID. Her doctor told her to hold off on taking the vaccine due to the recent COVID infection. She experienced a sore throat, body ache, low grade fever and cough. The cough lasted for 3 weeks, the longest out of all symptoms. Her sore throat lasted for 7 days, body ache for 5 days and low grade fever for 3 days. She was prescribed Paxlovid by her physician for her diagnosis, but she never took any doses of it. Most symptoms improved, but body ache stayed relatively stable until it subsided 5 days later.  Company Comment: This spontaneous case reported by a patient concerns a 60-year-old female patient, with relevant medical condition hypertension, who experienced unexpected, non-serious AESI Covid19, approximately 8 months after receiving a third dose of mRNA-1273.  She had symptoms of sore throat, body aches, fever, and cough.  Her physician prescribed Paxlovid but she never took it.  Instead, she took Vitamin C, elderberry, and paracetamol.  The symptoms improved, though cough lasted the longest at around 3 weeks.  The outcome was recovered.  The ongoing Covid19 pandemic could be a contributory factor.  The patient's concurrent hypertension could also be a confounder.  The benefit risk relationship of mRNA-1273 is not affected by this report.; Sender's Comments: This spontaneous case reported by a patient concerns a 60-year-old female patient, with relevant medical condition hypertension, who experienced unexpected, non-serious AESI Covid19, approximately 8 months after receiving a third dose of mRNA-1273.  She had symptoms of sore throat, body aches, fever, and cough.  Her physician prescribed Paxlovid but she never took it.  Instead, she took Vitamin C, elderberry, and paracetamol.  The symptoms improved, though cough lasted the longest at around 3 weeks.  The outcome was recovered.  The ongoing Covid19 pandemic could be a contributory factor.  The patient's concurrent hypertension could also be a confounder.  The benefit risk relationship of mRNA-1273 is not affected by this report.